SENSEX
NIFTY
GOLD
USD/INR

Weather

image 30    C

Science & Environment News

The Siasat Daily

Science & Environment / The Siasat Daily

details

DCGI approves Takedas Dengue Vaccine QDENGA for India

New Delhi: Takeda Biopharmaceuticals India Pvt Ltd on Monday, July 20, said it has received market authorisation from the Drug Controller General of India (DCGI) for dengue prevention vaccine, QDENGA. QDENGA, the first dengue vaccine approved in India, is used for the prevention of dengue in individuals aged 4-60 years. It can be administered regardless Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .

20 Jul 2026 2:11 pm